Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

Review of Carcinoid Syndrome

Review of Carcinoid Syndrome

Review of Carcinoid Syndrome: what is is and how it is treated by Joel George et al (Hampshire Hospitals and Kings Healthcare Partners ENETs Centre of Excellence)  Online Publication Date: 19 Jun 2023 Neuroendocrine Cancers (aka neuroendocrine neoplasms or NENs) may...

read more
Neuroendocrine Cancer UK Announces Partnership with RareCan

Neuroendocrine Cancer UK Announces Partnership with RareCan

Neuroendocrine Cancer UK Announces Partnership with RareCan to help Facilitate Access to Clinical Trial Opportunities Neuroendocrine Cancer UK is excited to announce a partnership with RareCan to help grow cohorts of people with neuroendocrine cancer, empowering them...

read more
Ignite Your Passion for a Cause: Join the Firewalk Challenge

Ignite Your Passion for a Cause: Join the Firewalk Challenge

Neuroendocrine Cancer UK is thrilled to announce the upcoming Firewalk Challenge, a heart-pounding event that aims to raise vital funds for Neuroendocrine Cancer UK. This exhilarating challenge will take place on November 10, coinciding with World Neuroendocrine...

read more